Company news

Genetic Technologies Limited news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Genetic Technologies Acquires EasyDNA

July 19, 2021

US Patent Office Grants Foundational Pharmacogenomic Patent

June 11, 2021

GTG COVID-19 Risk Test launched in USA

May 31, 2021

COVID- 19 Risk Test Approved for Commercial Release

April 26, 2021

GTG signs 3-year US licence agreement for COVID risk test

March 3, 2021

Pause in Trading

March 1, 2021

1H21 Half Year Results

February 26, 2021

Genetic Technologies US$6.56 Million Capital Raising

January 21, 2021

Genetic Technologies appoints Simon Morriss as CEO

January 3, 2021

GTG Secures US and ANZ Distribution Rights for PREDICTIX

November 30, 2020

GTG Announces US$5.1 Million Capital Raising

July 17, 2020

Response to ASX Early Release of Information Query

July 3, 2020

US Patent Office Grants Key Risk Test Patent

June 19, 2020

US Prospectus Lodgement

May 29, 2020

Genetic Technologies Announces USD 8 Million capital raising

May 27, 2020

US$1.44 Million capital raising

April 21, 2020

US$1.8 Million Capital Raising

April 1, 2020

Market update on sales, early test results and launch of CIT

March 31, 2020

USA Form F3 Registration Statement Lodged with SEC

March 16, 2020

Receipt of Delisting Notification Letter from Nasdaq

March 15, 2020

Half Yearly Report and Accounts

February 27, 2020

Breast Cancer Test US Sales Update

January 7, 2020

Updated Form F-1 Prospectus SEC Filing

December 18, 2019

Form F-1 Prospectus SEC Filing

December 17, 2019

Genetype for Breast Cancer commissioned-Sales start Q1 2020

December 10, 2019

Response to Appendix 3Y Query

October 6, 2019

Non-Renounceable Rights Issue

October 4, 2019

Director Resignation

September 23, 2019

Collaboration Agreement signed between GTG and TGen

September 22, 2019

Reinstatement to Official Quotation

August 6, 2019

Suspension from Official Quotation

August 1, 2019

Quarterly Update and 4C

July 31, 2019

Genetic Technologies to Appeal Nasdaq Delisting Notice

July 30, 2019

Cleansing Notice

July 16, 2019

GTG Announces Offering of American Depositary Shares

May 23, 2019

New Product Announcement

May 9, 2019

Operational Update & Appendix 4C

April 30, 2019

TGen MoU Accouncement

April 7, 2019

Genetic Technologies Company Profile

April 3, 2019

China Announcement

March 27, 2019

Investor Presentation 19 March 2019

March 19, 2019

ASX Lodgement Supplementary Prospectus

February 18, 2019

GTG US and UK Research Collaboration

February 1, 2019

End of Year R&D Update

December 21, 2018

Blockshine Health ASX Announcement

December 20, 2018

2018 Annual General Meeting materials

November 28, 2018

Lodgement Prospectus and Appendix 3B

November 18, 2018

Quarterly Activities Report & Appendix 4C - 30 Sept. 2018

October 29, 2018

GTG Invited to Establish Market Presence in Hainan, China

September 17, 2018

Appendix 4E and Financial Report 2018

August 29, 2018

← Newer news releases · Older news releases →

Decks

The 5 newest of 55 decks. Every deck is listed under its year.